LAST PRICE - AT THE CLOSE
DRUG is DOWN -15% since the begininning of the year
DRUG is DOWN -5% BELOW 20 day SMA
DRUG is DOWN -9% BELOW 200 day SMA
PROFITABLE: NO
EPS: $-0.793275
EARNINGS MOMENTUM: YES
0.38% INCREASE IN QTRLY EARNINGS
P/E RATIO IS: N/A
INCOME TO DEBT RATIO: 0.00
![]() |
THE STOCK IS 46.5% AWAY FROM ALL-TIME HIGHS OF $123.75 |
![]() |
DRUG IS DOWN -15% SINCE THE BEGINNING OF THE YEAR |
![]() |
DRUG IS UP 154% OVER THE PAST 12 MONTHS |
![]() |
DRUG IS DOWN -23% OVER THE PAST 1 MONTH |
![]() |
11% OF ALL DRUG INVESTORS ARE BETTING AGAINST DRUG |
![]() |
NUM INVESTORS SHORT DRUG HAS GONE UP N/A% VERSUS LAST MONTH |
![]() |
DRUG moved down N/A in the previous minute |
![]() |
DRUG is up N/A over the last hour |
![]() |
DRUG is up 100% over the last 5 days |
![]() |
DRUG is 100 above its 8 day SMA |
| $0.00 | DAY |
$0.00 |
| $63.18 | ![]() PREVIOUS DAY |
$68.54 |
| $58.10 | ![]() WEEK |
$68.54 |
| $56.47 | ![]() MONTH |
$92.00 |
| $23.18 | ![]() YEAR |
$123.75 |
DRUG is mentioned N/A less than normal on
DRUG is mentioned N/A times in an average day on